Your browser doesn't support javascript.
loading
Prophylactic para-aortic lymph node dissection in Colo-rectal cancer; pilot study.
Abdalwahab, Abdalwahab R; Abdelhamed, Mohamed A; Gad, Mai; Allam, Rasha Mahmood; Hussien, Alaadin.
Affiliation
  • Abdalwahab AR; Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt. Abdalwahab.raafat@cu.edu.eg.
  • Abdelhamed MA; Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Gad M; Department of Surgical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Allam RM; Department of Epidemiology and Biostatistics, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Hussien A; Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
World J Surg Oncol ; 22(1): 253, 2024 Sep 19.
Article in En | MEDLINE | ID: mdl-39300543
ABSTRACT

BACKGROUND:

Colorectal cancer is the 3rd most common cancer worldwide, representing 10% of all cancer types, and is considered the 2nd leading cause of cancer-related deaths. It usually metastasizes to the liver or lung. Para-aortic lymph node metastasis is considered a metastatic disease (stage 4) according to the AJCC and is considered a regional disease (stage 3) according to the JSCCR. Para-aortic lymph node metastases occur in about 1% of cases. Neoadjuvant CTH, followed by PALN, is the best option for metastatic para-aortic LNs in colorectal cancer patients. This study addresses the value of prophylactic para-aortic LN dissection among colon-rectal cancer patients (overtreatment protocol).

METHODOLOGY:

This is a prospective study that included patients attending NCI, Cairo University, from December 2020 to December 2023 who were complaining of left colonic cancer or recto-sigmoid cancer and underwent left hemicolectomy, sigmoid colectomy, or LAR. All patients underwent formal mesenteric LN dissection and prophylactic para-aortic LN dissection.

RESULTS:

Among 60 patients who underwent colorectal surgery with prophylactic para-aortic LN dissection, 21 cases (35%) were in the descending colon, 22 cases (36.7%) were in the sigmoid colon, 11 cases (18.3%) were in the recto-sigmoid, and 6 cases (10%) were in the upper rectum. 55 cases (91.7%) were in grade 2, and 5 cases (8.3%) were in grade 3. Neoadjuvant CTH was given in 3 cases (5%) while neoadjuvant RTH was given in 6 cases (10%). Regarding reported postoperative complications, lymphorrhea was reported in 2 patients (3.3%) and wound infection occurred in 6 patients (10%). A recurrence was reported among 8 cases (13.4%).

CONCLUSIONS:

We aimed in this study to highlight the value of prophylactic para-aortic lymph node dissection among colorectal cancer patients (over-treatment protocol) and report its reflection on predicting the behavior of the disease and subsequently selecting the patients who will be suitable to do this procedure.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Lymph Node Excision Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: World J Surg Oncol Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Lymph Node Excision Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: World J Surg Oncol Year: 2024 Document type: Article Affiliation country: Country of publication: